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The effect of vitamin E on the blood-brain barrier (BBB) permeability was studied under 
conditions of pentylenetetrazole (PTZ)-induced convulsions in aged (23- to 24-month-old) male 
albino rats; Evans Blue was used as a tracer. The BBB permeability was found to considerably 
increase in rats with PTZ-evoked seizures; the Evans Blue contents in the left and right 
hemispheres and cerebellum + brainstem region were significantly higher than those in the 
control. Vitamin E used in the dose of 70 mg/kg exerted practically no beneficial effect on the 
increased BBB permeability in rats with seizures, while a greater dose of vitamin E (700 mg/kg) 
exerted a significant protective effect, especially with respect to the cerebellum + brainstem 
regions (P < 0.01). The seizure-related rise in the arterial blood pressure was also smaller 
in the latter experimental group. Thus, our observations confirm the importance of the dose 
of vitamin E as a protective factor for the BBB permeability and demonstrate that the dose 
dependence of this antioxidant in aged animals differs from that in younger organisms.
Keywords: epilepsy, seizures, blood-brain barrier, permeability, pentylenetetrazole, 
vitamin E, geriatric.
1 Halic University School of Health Sciences, Halic University, Istanbul, 
Turkey.
2 Faculty of Medicine,Yeditepe University, Istanbul, Turkey.
3 Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Correspondence should be addressed to Hatice Yorulmaz
(e-mail: haticeyorulmaz@halic.edu.tr).
INTRODUCTION
Epilepsy is a disease characterized by recurrent 
epileptic seizure attacks induced by significantly 
transformed cerebral activity. It was found that the 
development of such attacks is related to the appearance 
of a great amount of reactive oxygen species (ROSs) 
within the brain [1]. The state of epileptic attacks 
allows the molecules of polar compounds, proteins, 
neurotransmitters, and other agents of large molecular 
weights to permeate much easier into the brain 
because of demolishing of the blood-brain barrier 
(BBB) [2, 3]. Additionally, membrane phospholipids 
release arachidonic acid due to increased oxygen 
consumption during the attacks [4]. Production of 
free radicals increases under such conditions, in 
particular, due to metabolization of arachidonic acid 
by cyclooxygenase. [5]. Free radicals can play the 
role of a powerful effector causing an increment in the 
BBB permeability; this can result in the creation of 
insults in the cerebral vascular endothelium [6, 7]. 
Biological effects of free radicals are controlled in 
vivo by a number of antioxidants, such as vitamins 
E, C, and A and glutathione [8, 9]. Vitamin E is one 
of the most important chain-breaking antioxidants; it 
provides oxidative phosphorylation to continue (by 
preventing accumulation of high-energy phosphates 
in the mitochondria) and protects cell membranes 
against oxidative insult by regulating production of 
free radicals [10, 11]. 
In our studies, we found that vitamin E exerts a 
protective effect on the BBB in the course of epileptiform 
attacks created by introduction of pentylenetetrazole 
(PTZ) in young and adult rats [12]. However, the effect 
of vitamin E on the BBB permeability under conditions 
of convulsions constituted in aged organisms is not 
clear. In this study, we intended to examine the effect 
of vitamin E on the BBB permeability in the case of 
PTZ-induced convulsions in aged animals and the dose 
dependence of this effect.
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METHODS
The experimental procedure was in accordance with 
the Helsinki Declaration (2004). Forty aged (23- to 
24-month-old) Wistar albino rats were used in the 
experiments. The animals were divided into four 
groups: group 1 (control), group 2 (animals with PTZ-
induced convulsions, PTZ group), and groups 3 and 
4 (rats manifesting such PTZ-evoked convulsions and 
treated with vitamin E in doses 70 and 700 mg/kg, 
groups PTZ + E70 and PTZ + 700, respectively). Each 
group consisted of 10 animals.
Cannulations of the femoral artery and vein were 
performed in animals under ether anesthesia. The 
blood pressure was measured in the above artery. The 
BBB permeability was characterized using an Evans 
Blue tracer (4 ml/kg, i.v.). Pentylenetetrazole was i.v. 
injected in the dose of 100 mg/kg into rats of groups 2 
to 4, in order to induce convulsions after Evans Blue 
was given. Vitamin E was i.p. injected 30 min before 
Evans Blue injection in the above-mentioned doses 
(70 and 700 mg/kg) in rats of groups 3 and 4. The 
seizure attacks were monitored for 20 min. Generalized 
convulsions characterized by tonic/clonic contractions 
of the limb and trunk muscles were observed in all 
animals. 
The brains of the rats were elutriated by perfusion 
with 0.9% NaCl solution via the left ventricle 25 min 
after Evans Blue injection. Then, the brains were 
dissected and separated into the left hemisphere, right 
hemisphere, and cerebellum + brainstem regions. 
Wet masses of the dissected samples were measured. 
Afterwards, each brain region was homogenized 
by placing in tubes with phosphate buffer (2.5 ml). 
A 60% solution of trichloroacetic acid (2.5 ml) was 
put in each tube after homogenizing; this procedure 
provided separation of Evans Blue from albumins by 
centrifuging with a vortex for 2 min. After the vortex 
process, the tubes were kept at 4°C for 30 min and 
centrifuged at 1,000g for 30 min. After centrifuging, the 
absorbance values were read spectrophotometrically 
at a 620 nm wavelength (after decanting supernatants 
to spectrophotometer tubes). The Evans Blue content 
values (µg/mg tissue) were calculated for brain tissue 
samples using the Evans Blue absorbance-quantity 
regression equation and catenary via the obtained 
absorbance values. The statistical analysis was 
performed using ANOVA.
RESULTS
No differences were observed from the aspect of 
intensity of the tonic/clonic contraction phase during 
the epileptic attacks in groups 2-4 of rats injected 
with PTZ. The averaged values of blood pressure in 
all animal groups are shown in Fig. 1. As can be seen, 
no significant differences of the pre-seizure blood 
pressure values in groups 2-4 from those in group 1 
(control) were observed. The development of PTZ-
induced convulsions resulted in a significant increase 
(by about 42%) in the blood pressure in group 2. 
Injection of vitamin E in a smaller dose (group 3) 
exerted no effect on the value of this shift. At the same 
time, in group 4 (PTZ + E700), a seizure-related rise in 
the blood pressure was also significant, as compared 
with the control, but noticeably less intense (by about 
32%) than that in group 3.
In control animals (group 1), the mean Evans Blue 
concentrations in the left and right hemispheres and 
in the cerebellum + brainstem regions were found to 
be 0.288 ± 0.067, 0.295 ± 0.076, and 0.368 ± 0.078 
(M ± s.d.) µg/mg tissue, respectively. The corresponding 
values in group 2 after the development of PTZ-induced 
seizures were noticeably higher (0.521 ± 0.158, 0.404 ± 
± 0.045, and 0.879 ± 0.232 µg/mg tissue, i.e., the 
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Fig 1. Mean values of the arterial blood pressure (mm Hg) in groups 
1-4 of experimental rats. 1) Control group, 2) animal group with 
pentylenetetrazole (PTZ)-induced convulsions, 3 and 4) groups of 
rats with such seizures treated with vitamin E in doses of 70 (3) and 
700 (4) mg/kg. In 2-4, open and filled columns correspond to the 
blood pressure values measured before PTZ injections and to those 
measured within the seizure period, respectively. Means ± s.d. are 
shown. Asterisks show cases of a significant difference from control 
(P < 0.05).
Р и с. 1. Середні значення артеріального кров’яного тиску в 
групах 1–4 (1-4) експериментальних щурів.
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increments were 81, 37, and 128 %, respectively 
(P < 0.05 or P < 0.01; Fig. 2). These shifts were indicative 
of a significant increase in the BBB permeability in 
the course of PTZ-induced convulsions. 
When aged rats with PTZ-induced seizure activity 
were treated with vitamin E in the smaller dose used 
(70 mg/kg; PTZ + E70 group), the mean Evans Blue 
concentrations in the above-mentioned cerebral 
regions were the following: 0.618 ± 0.159 and 0.611 ± 
± 0.171 µg/mg tissue in the left and right hemisphere 
and 0.713 ± 0.183 µg/mg in the cerebellum + brainstem 
(Fig. 2). Thus, vitamin E applied in the above dose 
exerted practically no beneficial effect on the increased 
BBB permeability. The Evans Blue contents in the 
hemispheres were even somewhat greater than those 
in group 2. The content of the dye in the cerebellum + 
+ brainstem was mildly (by 18 %) smaller than the 
respective value in group 2, but the difference was 
insignificant (P > 0.05).
In group 4 (rats with PTZ-induced convulsion 
activity treated with vitamin E in the greater dose, 
700 mg/kg), the amount of Evans Blue in the left 
hemisphere was insignificantly smaller (P > 0.05) 
than that in group 2 (PTZ), and this index in the right 
hemisphere was nearly the same as that in the latter 
group (with no vitamin E). At the same time, the mean 
concentration of the dye in the cerebellum + brainstem 
of group-4 rats (0.511 ± 0.105 µg/mg) was 37 % lower 
(P < 0.01) than the respective value in group 2 
(Fig. 2). 
Greater values of standard deviations of the Evans 
Blue contents in brain tissues of animals of groups 
2-4, as compared with the corresponding figures in 
the control group 1, should be, probably, especially 
mentioned. In other words, the individual variability 
of the state of the BBB in animals with PTZ-induced 
seizures (both treated and not treated with vitamin E) 
was rather extensive.
DISCUSSION
Our experiments demonstrated that: i) vitamin E is 
capable, in principle, of exerting a protective effect on 
the disturbed BBB permeability in old animals with 
experimentally induced epileptiform seizure activity, 
and ii) the respective effects in aged rats differ 
significantly from those in younger animals.
The BBB permeability was shown to considerably 
increase during epileptic seizure attacks [2, 13]. As was 
suggested, increased production of ROSs represents 
one of the crucial factors providing greater BBB 
permeability values during an after such attacks [12, 
14]. A protective effect of vitamin E, which is well-
known as an important antioxidant agent, in particular 
with respect to endothelial cells, was demonstrated in 
a few studies [12, 15]. 
A significant increment in the arachidonic acid 
concentration together with that for free fatty acids 
was observed in experiments with PTZ-induced seizure 
attacks [4]. Metabolization of arachidonic acid with 
the involvement of cyclooxygenase and lipooxigenase 
causes intensified free radical generation [5]. Free 
radicals primarily start lipid peroxidation by reacting 
with unsaturated fatty acids in cell and organelle 
membranes [8]. Lipid peroxidation in the cerebral 
endothelial cell membranes is, probably, one of the 
main reasons for an increment in the BBB permeability 
[6, 7]. The antioxidants, such as vitamins A, C, and 
(especially) E were shown to exert a protective effect 
on the BBB during epileptic attacks [12, 15, 17]. 
Vitamin E inactivates lipid peroxyl, superoxides, and 
other reactive species [10, 18]. The most important 
cellular function of vitamin E is to protect cell 
membranes by inhibiting peroxidation of unsaturated 
fatty acids [19].
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Fig. 2. Contents of the tracer (Evans Blue, µg/mg tissue) in samples 
of the left brain hemisphere, right hemisphere, and cerebellum + 
+ brainstem regions (A-C, respectively) in groups 1-4 of experimental 
rats. Intragroup means ± s.d. are shown. Designations of animal 
groups are the same as in Fig. 1. One and two asterisks show cases 
of significant differences (P < 0.05 and P < 0.01, respectively) 
from the control group 1; two crosses show a significant difference 
(P < 0.01) from the value in group 2 (PTZ).
Р и с. 2. Вміст трасера (Еванса блакитного, мкг/мг тканини) у 
зразках лівої та правої мозкових півкуль та ділянки мозочка й 
стовбура мозку (А–C відповідно) у групах експериментальних 
тварин 1–4 (1-4). 
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Vitamin E was shown to decrease the intensity of 
acute PTZ-sourced attacks in rats [20]. The levels 
of this vitamin in the blood plasma of children 
suffering from seizures were found to be lower than 
the respective values in control children of the same 
age [21]. Furthermore, an anti-attack effect of vitamin 
E was observed under experimental conditions, 
such as ferrous chloride model, hyperbaric oxygen 
model, kindling, and PTZ-evoked seizure activity 
[20, 22, 23]. 
In our study, a sufficiently high dose of vitamin E 
demonstrated a clear protective effect against seizure-
related increase in the BBB permeability in old rats; 
this was especially considerable with respect to the 
cerebellum + brainstem regions of experimental 
animals. This observation contradicts results of some 
other studies were no protective effect of vitamin E on 
epileptic attacks created by PTZ and other chemical 
convulsants was found [24, 25]. These contradictions 
are probably related to the fact that antioxidants 
manifest dissimilar anticonvulsant effects depending 
on the type of the convulsant or subeffective doses. 
Vitamin E administered in 300 or 500 mg/kg doses was 
shown to moderate the intensity of penicillin-sourced 
epileptiform activity in rats [26]. As was mentioned 
above, we found that this vitamin demonstrated a 
protective effect against seizure-related disorders of 
the BBB permeability in young and adult rats, and the 
70 mg/kg dose was effective [12]. At the same time, it 
is well-known that there are noticeable age-dependent 
modifications of the epileptic and epileptiform activity 
[27]. The threshold value for the attacks created by 
PTZ introductions is higher in old animals, durations 
of generalized attacks are longer in this age group than 
in adults, and old animals are distinguished by a higher 
relapse ratio [28, 29]. In this our study, we found that 
the 70 mg/kg dose of vitamin E exerts practically no 
protective effect on the BBB under conditions of PTZ-
induced seizures in aged rats; such an effect appears 
only in the case of a much higher dose.
Alterations in the neuromodulatory systems 
depending on aging constitute the most probable 
reason for these dissimilarities. As was shown, these 
systems regulate in vivo the epileptiform activity and 
significantly influence the relapse severity, sensitivity, 
and prevalence [30, 31]. Considerable modifications of 
synaptic connections, electrotonic coupling, features 
of receptors and channels, numbers and functions 
of specific-type neurons within neuronal networks 
develop due to aging [32-37]. Besides this, it was 
reported that age-dependent alterations also develop 
in the sodium/potassium equilibrium and extracellular 
volume, and these alterations noticeably affect neuronal 
synchronization and excitability [38-41]. Thus, much 
higher doses of vitamin E are needed to provide its 
protective effect against the increased permeability of 
the BBB during epileptic attacks in old organism. 
The fact that Evans Blue contents in the hemispheres 
of rats in the PTZ + E70 group 3 were found to be not 
lower but even somewhat higher than the respective 
figures in group 2 (PTZ) may have two explanations. 
First, this can result from an occasional deviation 
mostly related to a high dispersion of this index in all 
PTZ groups. Another interpretation, however, should 
also be taken into account. Vitamin E, probably, 
cannot be considered an "absolute" antioxidant. There 
are indications that this vitamin is a redox reagent that 
can, under certain conditions, function as a prooxidant 
[42-45]. Thus, in some cases it probably can somewhat 
increase the disturbed BBB permeability. 
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Р е з ю м е
На старих (вік 23–24 місяці) самцях білих щурів дослід-
жували вплив вітаміну Е на розлади проникності гемато-
енцефалічного бар’єра (ГЕБ), пов’язані з розвитком 
судомної активності, котра була індукована введенням пен-
тилентетразолу (ПТЗ); як трасер використовували барвник 
Еванс блакитний. У тварин із ПТЗ-викликаними судома-
ми проникність ГЕБ значно збільшувалася; вміст барвни-
ка в тканинах лівої та правої мозкових півкуль, мозочка та 
стовбура мозку вірогідно перевищував відповідні значення 
в контролі. Вітамін Е в дозі 70 мг/кг практично не справ-
ляв позитивного впливу на збільшену проникність ГЕБ у 
тварин із судомною активністю. Застосування ж вітамі-
ну Е в більших дозах (700 мг/кг) забезпечувало істотний 
протективний ефект, особливо щодо зразків тканин мозоч-
ка та стовбура мозку (P < 0.01). Підвищення  артеріально-
го кров’яного тиску, пов’язане з розвитком судом, в остан-
ній з експериментальних серій було помірнішим, ніж у двох 
інших серіях. Отже, наші спостереження підтверджують 
важливість дозування вітаміну Е як протективного фактора 
щодо проникності ГЕБ та вказують на те, що залежність від 
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дози цього вітаміну, використовуваного як антиоксидант, у 
старих тварин істотно відрізняється від такої у молодших 
організмів.
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